Clinical trial

Risperdal Consta and Health Care Utilization in Patients With Schizophrenia

NCT00313391

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-12-01

PhasePHASE4

Study timeline

Study start (unknown)2005-12-01Date precision: month

Registry last updated2014-09-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Schizoaffective Disorderunresolved

Interventions

Risperdal ConstaDRUG

Sponsors & collaborators

Emory Universitylead sponsor

Janssen, L.P. - Investigator Initiated Studies Programcollaborator

Mapped research locations

AtlantaGeorgia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00313391 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.